News
| 2 min read
CareDx, IDbyDNA strike up partnership for infectious disease testing in transplant patients
| 2 min read
Distributed Bio adds large-molecule discovery platform to Charles River's repertoire
| 2 min read
Vir Biotechnology initiates Phase 1 trial to evaluate a novel HIV vaccine platform
| 3 min read
Repeated infusions reduce severity of symptoms in chronic post-traumatic stress disorder
| 3 min read
Hoth Therapeutics collaborates with USAMRDC to treat multi-drug resistant bacterial lung infections
| 2 min read
In lab experiments, pralatrexate outperformed remdesivir against SARS-CoV-2
| 2 min read
PRX-102 concludes Phase 3 trial in Fabry disease, improves renal function
| 3 min read
The companies will advance the gonadotropin-releasing hormone receptor antagonist in advanced prostate cancer and two women's health indications
| 3 min read
Altimmune begins Phase 2 clinical trial of HepTcell, an immunotherapeutic for chronic hepatitis B
| 2 min read
Dapansutrile prevents inflammatory response, and restores cognitive and behavioral deficits in an Alzheimer’s mouse model
| 2 min read
Soligenix gains a $1.5 million Small Business Innovation Research award for COVID-19 and ebola vaccines
| 3 min read
Researchers find that chromothripsis results in rearranged genomes and ecDNA that helps mutated cells evade treatment
